FLNA

Filana Therapeutics, Inc. - Common Stock (FLNA)

About Filana Therapeutics, Inc. - Common Stock (FLNA)

Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

Details

Daily high

$1.04

Daily low

$0.93

Price at open

$0.96

52 Week High

$4.98

52 Week Low

$0.67

Market cap

46.6M

Dividend yield

Volume

1.7M

Avg. volume

6.0M

P/E ratio

-1.10

Filana Therapeutics, Inc. - Common Stock News